96 filings
ARS
2023 FY
VERA
Vera Therapeutics Inc - Ordinary Shares
3 Apr 24
Annual report to shareholders
9:55pm
DEFA14A
VERA
Vera Therapeutics Inc - Ordinary Shares
3 Apr 24
Additional proxy soliciting materials
5:02pm
S-8
VERA
Vera Therapeutics Inc - Ordinary Shares
27 Mar 24
Registration of securities for employees
4:16pm
8-K
57w6pk
20 Mar 24
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:30am
8-K
uqr 83ae7
30 Jan 24
Other Events
4:54pm
424B5
14qzve
30 Jan 24
Prospectus supplement for primary offering
4:52pm
S-3MEF
k2kz9klfvkiu
29 Jan 24
Registration of additional securities for an S-3
9:58pm
424B5
k59ihjg
29 Jan 24
Prospectus supplement for primary offering
8:46am
8-K
j6cq0ur f9z
29 Jan 24
Results of Operations and Financial Condition
6:05am
8-K
52hy4xv2ncaps
25 Jan 24
Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy
6:31am
8-K
jtyel 8kq0
8 Jan 24
Departure of Directors or Certain Officers
8:05am
8-K
mf2eyrzen02vmgn cw
8 Jan 24
Regulation FD Disclosure
8:03am
8-K
pg49xti j2f5z
26 Dec 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:02pm
8-K
j271cmz2c01f3qc
9 Nov 23
Vera Therapeutics Provides Business Update and Reports Third Quarter Financial Results
8:00am
8-K
ukjn27ee
10 Aug 23
Vera Therapeutics Provides Business Update and Reports Second Quarter Financial Results
8:01am
8-K
m1r7h
20 Jun 23
Regulation FD Disclosure
7:50am